Standardizing Outcome Measures for Neurodevelopmental Disorders: A Game-Changer for ADHD Diagnosis and Treatment

Strategic Insights -

Research from the University of Melbourne, Australia, has led to the development of a standardized core set of outcome measures for specific neurodevelopmental disorders, including attention-deficit/hyperactivity disorder (ADHD). This breakthrough study emphasizes the importance of using evidence-based, reliable, and accessible measures to guide clinical decision-making in mental health.

Key Takeaways:

  • The International Consensus on Standard Outcome Measures for Neurodevelopmental Disorders study brings together a working group of 27 clinical and research experts, as well as service users, to develop a standard core set of outcome measures for children and adolescents with neurodevelopmental disorders (NDDs).
  • The final set recommends measuring 12 outcomes across 3 key domains: core symptoms related to the diagnosis, impact, functioning, and quality of life, and common coexisting problems.
  • The working group defined the scope, outcomes, included measures, case-mix variables, and measurement time points using a modified Delphi approach.
  • The core set of measures, which includes 14 assessments, was developed after an international working group participated in video conference calls and surveys between March 2021 and June 2022.
  • The measures were first validated with 32 professionals and 40 service users, who completed an open review survey.
  • More than 70% of professionals and service users endorsed the NDD set items in the open review survey, providing confidence in its validity and reliability.

Statistics:

  • 27 experts and service users contributed to the development of the NDD set of outcome measures.
  • 32 professionals and 40 service users participated in the external review survey.
  • 14 assessments are recommended to measure the 12 outcomes across the 3 key domains.
  • 12 outcomes are prioritized to be measured by the NDD set: 7 related to core symptoms, and 5 related to coexisting problems.
  • Measures are recommended to be administered at least every 6 months to monitor outcomes.
  • The external review survey was completed by 72% of professionals and 80% of service users.

Sources:

  • International Consensus on Standard Outcome Measures for Neurodevelopmental Disorders, JAMA Network Open, 2024,7(6).
  • American Medical Association, JAMA Network Open, https://jamanetwork.com/journals/jamanetworkopen.
  • Melissa Mulraney, Department of Pediatrics, University of Melbourne, Parkville, Australia.
  • International Consensus on Standard Outcome Measures for Neurodevelopmental Disorders, Mental Health Weekly Digest, July 1, 2024, p 379.